In short. Fillers understood as a class of substances rather than a product list: the divide between dissolvable and non-dissolvable filler families, reversibility, and honest longevity.

Key points

  • Being able to dissolve a material is not only a convenience for correcting an aesthetic result.
  • In the rare event of a vascular problem, the ability to break the filler down is part of how the situation is managed.
  • That property belongs to the hyaluronic-acid family, and it is a reasonable factor in choosing a first treatment.

Dermal fillers are usually discussed as a list of products. A more useful way to think about them is as a class of substances with different origins, different behaviour in tissue, and different exit routes. Once the class is clear, the product conversation becomes a technical detail rather than a decision made from advertising.

The class divide that matters

The most important line is between fillers made of hyaluronic acid and fillers that are not. That line decides whether the material can be dissolved, whether it adds volume immediately or works through the skin’s own response, and how long it is likely to last. Everything else is nuance within one side of the divide.

Hyaluronic acid and reversibility

Hyaluronic acid is a sugar molecule that occurs naturally in the body, and in skin it binds water and contributes to hydration and plumpness. As a filler it is formulated into a gel that adds volume where it is placed, and the body gradually breaks it down over months. Its distinguishing feature is that a specific enzyme can dissolve it. If a result is unsatisfactory, or a rare vascular complication occurs, the material can be removed rather than left to fade.

Non-hyaluronic-acid fillers

The other families include calcium-based collagen stimulators, poly-L-lactic acid, and polycaprolactone. These are not enzyme-reversible. They are used for different purposes, mostly to stimulate the skin’s own collagen response rather than to add immediate volume, and they should be chosen deliberately, because the decision cannot be undone on the day it is regretted.

Reversibility is a safety feature

Being able to dissolve a material is not only a convenience for correcting an aesthetic result. In the rare event of a vascular problem, the ability to break the filler down is part of how the situation is managed. That property belongs to the hyaluronic-acid family, and it is a reasonable factor in choosing a first treatment.

Volume now versus collagen over months

A conventional hyaluronic-acid filler changes the contour as soon as it is placed. A biostimulator does not. It works by provoking a controlled collagen response in the tissue, so its effect appears over months as new collagen is laid down. Patients who expect an instant mirror change from a biostimulator are often disappointed; patients who judge one at two weeks are judging it too early.

How long it lasts, stated honestly

Longevity varies by product family, by the area treated, and by the individual. Movement, the depth of placement, and the person’s own tissue metabolism all matter. The honest range is generally months to more than a year, and no filler is permanent or predictable to the month. Anyone who names a precise duration before assessing the area and the patient is guessing.

Ask which filler family is proposed, and why

  • Reversibility differs between families, and so does what can be done if the result needs correcting.
  • One family adds volume immediately while another works through collagen over months, so know which timeline you are agreeing to.
  • Different families suit different problems, so the choice should follow the diagnosis rather than a preference or a promotion.

Related reading

Frequently asked questions

Why does reversibility matter so much in choosing a filler?

An enzyme can dissolve hyaluronic-acid filler, so a disappointing result can be corrected and a rare vascular complication can be treated by breaking the material down. Non-hyaluronic-acid families cannot be undone this way, so that choice has to be deliberate and discussed beforehand.

Why is a biostimulator judged too early at two weeks?

Because it works by provoking a controlled collagen response rather than adding volume directly. The change appears over months as new collagen is laid down, so judging at two weeks understates it. Patients expecting an instant mirror change are usually disappointed.

Can anyone state exactly how long a filler will last?

No. Longevity varies with the product family, the area treated, movement, the depth of placement and the individual metabolism of the tissue. The honest range is generally months to more than a year, and no filler is permanent or predictable to the month.

Risks & Limitations

  • Vascular occlusion — a time-critical emergency in which filler blocks a blood vessel. It can cause skin loss and, rarely, blindness.
  • Nodules, lumps or granuloma formation, which may need treatment or dissolution.
  • Infection at the injection site.
  • Asymmetry or over-correction; over-treatment is harder to correct than under-treatment.
  • Migration of filler away from the intended area.
  • Temporary brow or eyelid droop after botulinum toxin, which resolves as the effect wears off.
  • Bruising and swelling. All injectable results are temporary and maintenance is required.

When to Seek Care

  • Severe pain out of proportion to the procedure, or skin turning white, grey, mottled or dusky — this is a vascular emergency; seek care immediately.
  • Any change in vision — seek emergency care immediately.
  • Fever, spreading redness, warmth or pus at an injection site.
  • A hard, painful lump that is growing.
  • Drooping eyelid, difficulty swallowing, or difficulty breathing after botulinum toxin.

References & Further Reading

  • American Academy of Dermatology (AAD) — injectable safety information
  • American Society of Plastic Surgeons (ASPS) — injectable guidance
  • U.S. Food and Drug Administration (FDA) — approved filler and neurotoxin products
  • National Medical Products Administration (NMPA, China) — approved product status

Medically reviewed by Ke He, MD (何锞), Deputy Director & Head of Skin & Laser Aesthetics. Last reviewed: 18 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.